| Stage | BDX | % of rev | MDT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.0B | 100.00% | $9.8B | 100.00% | MDT ×1.96 |
| Gross profit | $2.3B | 46.46% | $6.3B | 64.99% | MDT +18.5pp |
| Operating income | $663M | 13.31% | $1.8B | 18.08% | MDT +4.8pp |
| Pre-tax income | $554M | 11.12% | $1.8B | 18.13% | MDT +7.0pp |
| Net income | $377M | 7.57% | $1.5B | 15.16% | MDT +7.6pp |
| Stage | BDX | MDT | Gap · A − B |
|---|---|---|---|
| Revenue | $5.0B100.00% | $9.8B100.00% | MDT ×1.96 |
| Gross profit | 46.46%$2.3B | 64.99%$6.3B | MDT +18.5pp |
| Operating income | 13.31%$663M | 18.08%$1.8B | MDT +4.8pp |
| Pre-tax income | 11.12%$554M | 18.13%$1.8B | MDT +7.0pp |
| Net income |
| 7.57%$377M |
| 15.16%$1.5B |
| MDT +7.6pp |
No shared counterparties.